Skip to main content

DexCom, Inc. (DXCM)

NASDAQ: DXCM · IEX Real-Time Price · USD
560.83 4.29 (0.77%)
Oct 21, 2021 12:08 PM EDT - Market open
Market Cap53.22B
Revenue (ttm)2.17B
Net Income (ttm)530.60M
Shares Out96.70M
EPS (ttm)5.34
PE Ratio105.06
Forward PE156.25
Ex-Dividend Daten/a
Previous Close556.54
Day's Range550.00 - 561.19
52-Week Range305.63 - 579.00
Price Target544.10 (-3.0%)
Est. Earnings DateOct 28, 2021

About DXCM

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LL...

IndustryHealth Care Equipment & Supplies
IPO DateApr 14, 2005
CEOKevin Sayer
Stock ExchangeNASDAQ
Ticker SymbolDXCM
Full Company Profile

Financial Performance

In 2020, DexCom's revenue was $1.93 billion, an increase of 30.54% compared to the previous year's $1.48 billion. Earnings were $493.60 million, an increase of 388.23%.

Financial Statements

Analyst Forecast

According to 21 analysts, the average rating for DexCom stock is "Buy." The 12-month stock price forecast is 544.10, which is a decrease of -2.98% from the latest price.

Price Target
(-2.98% downside)
Analyst Consensus: Buy


2 Unstoppable Stocks to Buy and Hold for Decades

These are investments that you won't need to worry about.

Other symbols:MSFT
4 hours ago - The Motley Fool

Will DexCom (DXCM) Beat Estimates Again in Its Next Earnings Report?

DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

22 hours ago - Zacks Investment Research

Dexcom Expands Time in Range Initiative with Nick Jonas to Help Improve the Lives of People with Diabetes in the UK

LONDON--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in continuous glucose monitoring for people with diabetes, today announced the UK launch of its Time in Range Campaign, an awarenes...

1 week ago - Business Wire

Got $1,000? These 2 High-Growth Stocks Are Screaming Buys Right Now

Both companies are in industries with strong opportunity ahead.

Other symbols:GRWG
1 week ago - The Motley Fool

Here's Why You Should Add DexCom (DXCM) Stock to Your Portfolio

Investors continue to be optimistic about DexCom (DXCM) owing to its slew of favorable coverage decisions for its G6 CGM System.

1 week ago - Zacks Investment Research

Stocks Rebound, But Will Rally Attempt Have Legs? Datadog, Microsoft, Dexcom Show Strength

Stocks rebound, but will rally attempt have legs? Datadog, Microsoft, Dexcom show strength.

Other symbols:DDOG
2 weeks ago - Investors Business Daily

Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time

SAN DIEGO--(BUSINESS WIRE)--Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time.

2 weeks ago - Business Wire

3 Innovative Growth Stocks That'll Make You Richer Through 2025

Their products are better than those of their rivals, and their leads are increasing.

Other symbols:ORGOPGNY
2 weeks ago - The Motley Fool

Dexcom's (DXCM) G6 CGM System Gets Coverage in Manitoba

Dexcom's (DXCM) CGM System is expected to simplify diabetes management due to increasing access to the life changing technology.

2 weeks ago - Zacks Investment Research

1 Supercharged Healthcare Stock to Buy Right Now

The stock isn't a household name, but it's generated multibagger returns over the past five years alone.

3 weeks ago - The Motley Fool

This Stock Is Likely To Outperform Abbott Laboratories

We think that Dexcom stock currently is a better pick compared to Abbott stock, despite Dexcom being more expensive of the two. Dexcom trades at about 25x trailing revenues, compared to just 5x for Abbott.

3 weeks ago - Forbes

Dexcom G6 Continuous Glucose Monitoring System Now Covered in Manitoba for Young People With Type 1 Diabetes

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom G6 Continuous Glucose Monitoring System now Covered in Manitoba for Young People With Type 1 Diabetes

3 weeks ago - Business Wire

Ignore GameStop: Here Are 2 Better Stocks

The performance of these two companies isn't detached from their financial results.

Other symbols:NFLX
3 weeks ago - The Motley Fool

Will Dexcom Stock Continue To Make Fresh Highs?

A few months back we discussed that going by its historical performance Dexcom Stock may continue to rally after a 23% rise in a month. DXCM stock has since rallied 34%, while it is up 11% over the last...

3 weeks ago - Forbes

5 Medtech Stocks to Seize Major Growth

The merging of healthcare and technology is changing how we care for our bodies. It's also creating investment opportunities, such as these five medical technology stocks.

Other symbols:ILMNTDOCVEEV
1 month ago - Kiplinger

2 Sizzling Hot Stocks to Buy Right Now

These two stocks could make you richer in 2021 and beyond.

Other symbols:NVDA
1 month ago - The Motley Fool

Dexcom's (DXCM) G6 CGM Under NIHB Program to Aid More Patients

Expanded access to Dexcom's (DXCM) G6 CGM for clients enrolled in NIHB is expected to aid a wider patient pool to better manage their diabetes.

1 month ago - Zacks Investment Research

Non-insured Health Benefits Program Now Covers Dexcom G6 Continuous Glucose Monitoring System for Children and Adoles...

BURNABY, British Columbia--(BUSINESS WIRE)--Non-Insured Health Benefits Program now Covers Dexcom G6 CGM System for Children and Adolescents on Intensive Insulin Therapy

1 month ago - Business Wire

This Smart Monitor Company Has Outperformed Apple, Google And Amazon Over The Last 5 Years

A smart monitor company that received FDA approval in 2015 has seen a five-year stock performance that has outperformed the returns of Apple Inc (NASDAQ: AAPL), Alphabet Inc (NASDAQ: GOOG)(NASDAQ: GOOGL...

1 month ago - Benzinga

3 Growth Stocks That'll Make You Richer By 2024

Their competition is in the rearview mirror, and customers are clamoring for their products.

Other symbols:ALGNISRG
1 month ago - The Motley Fool

Dexcom Announces Upcoming Virtual Conference Presentations

SAN DIEGO--(BUSINESS WIRE)--Dexcom Announces Upcoming Virtual Conference Presentations

1 month ago - Business Wire

Senseonic Stock Is Climbing After Bouncing Back From a Disappointing Q2

Despite a mixed Q2 2021 result, bullish sentiment is building for Senseonics. Here's why SENS stock can run-up in the future.

1 month ago - InvestorPlace

Moderna And DexCom Lead The Nasdaq-100

U.S. indices had a mixed day of trading Wednesday as investors weigh rising COVID-19 Delta variant cases nationwide. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained 0.17% to $380.58

Other symbols:MRNA
1 month ago - Benzinga

DexCom And O'Reilly Auto Parts Lead The QQQ Monday

U.S. indices bounced off Monday morning's lows as investors weigh weak China retail and production data. Uncertainty around the COVID-19 Delta variant is also weighing on the market.

Other symbols:QQQORLY
2 months ago - Benzinga

3 Growth Stocks to Buy and Hold Regardless of What Happens With the Delta Variant

These companies are still going to be great long-term buys.

Other symbols:FBFDX
2 months ago - The Motley Fool